The effectiveness of the use of the drug “Furinaid” in complex therapy in the treatment of idiopathic cystitis in small pets

Abstract

The disease of the lower urinary tract in cats is clinically significant pathology affecting about 7% of cats. Idiopathic feline cystitis (ICC) is diagnosed in more than half of cases of lower urinary tract disease in cats under the age of ten years. The cat HCC is a diagnosis of exclusion, in other words, urolithiasis and bacterial infections of the urinary tract should be excluded from the diagnosis. There are several reasons leading to the occurrence of diseases of the lower urinary system of cats. However, the idiopathic form of this disease (idiopathic cat cystitis) is one of the most common today. Stress, as it is now known, plays a very important role in the initiation and/or aggravation of the course of HCC. Worldwide, idiopathic cystitis is the most common cause of diseases of the lower urinary tract of cats, both males and females. The development of effective methods for the treatment of idiopathic cystitis in cats is one of the promising areas of veterinary science and practice. The article presents the results of studies obtained in assessing the effectiveness of the use of the drug “Furinaid” in complex therapy in the treatment of idiopathic cystitis in cats. Based on the obtained research results, it was found that 100% of the animals recovered in all the test groups, which indicates that the animals were properly treated, but the scheme using the drug “Furinaid” was therapeutically more effective. Therefore, it can be argued that in pharmacotherapy of idiopathic cystitis in cats, the use of drugs containing glucosaminoglycans is of great importance.